
Natera NTRA
€ 166.70
-2.52%
Quartalsbericht 2024-Q3
hinzugefügt 12.11.2024
Natera Langfristiger Schuldenstrom 2011-2026 | NTRA
Langfristiger Schuldenstrom Jährlich Natera
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.64 M | 5.75 M | 7.3 M | 5.74 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.64 M | 5.74 M | 6.61 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 23.96 | -3.0 % | $ 666 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 9.07 | -2.94 % | $ 1.97 B | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
662 K | $ 1.53 | -6.13 % | $ 2.04 M | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 25.62 | -5.6 % | $ 20 B | ||
|
Personalis
PSNL
|
7.7 M | $ 5.05 | -8.27 % | $ 299 M | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 20.44 | -6.71 % | $ 1.09 B | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 14.79 | -3.33 % | $ 447 M | ||
|
Illumina
ILMN
|
79 M | $ 120.84 | -4.79 % | $ 19.2 B | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 163.54 | -1.9 % | $ 8.11 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 56.8 | -3.97 % | $ 3.4 B | ||
|
Guardant Health
GH
|
27.7 M | $ 82.48 | -0.77 % | $ 10.3 B | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 81.06 | -2.98 % | $ 5.47 B | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
431 K | $ 1.99 | 2.9 % | $ 8.8 M | ||
|
Senseonics Holdings
SENS
|
496 K | $ 6.44 | -10.31 % | $ 269 M | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 411.04 | 0.31 % | $ 11.9 B | ||
|
Biomerica
BMRA
|
358 K | $ 2.16 | -1.22 % | $ 4.96 M | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 116.7 | 13.86 % | $ 9.63 B | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 256.03 | -1.35 % | $ 21.3 B | ||
|
NeoGenomics
NEO
|
4.78 M | $ 8.98 | -0.5 % | $ 1.15 B | ||
|
Celcuity
CELC
|
54 K | $ 118.45 | -1.35 % | $ 5.54 B | ||
|
National Research Corporation
NRC
|
451 K | $ 16.04 | -4.78 % | $ 359 M | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 4.68 | -3.41 % | $ 433 M | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 189.26 | -2.93 % | $ 21 B | ||
|
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | ||
|
OpGen
OPGN
|
174 K | - | -16.95 % | $ 1.54 M | ||
|
Organovo Holdings
ONVO
|
521 K | - | -2.3 % | $ 19.4 M |